http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TN-2014000268-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a693232b92910547c898db10feb83fef
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2014-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c977e6cbc30fb7c732da2ee026ab5ddc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed0b0ca4e604b35ae11c9992ab98cdfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9306219b32935a9ec6c3fdc1e8a4752
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_642befc9a1aa9fc15a64d768171b4e76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79fe9908630d2743bc5ab6a22248e25d
publicationDate 2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TN-2014000268-A1
titleOfInvention Quinoline derivatives as pde10a enzyme inhibitors
abstract The present invention provides quinoline derivatives of formula (I) that are PDE10A enzyme inhibitors, and as such are useful to treat neurodegenerative and psychiatric disorders. Especially, the invention provides compounds that are highly selective for PDE10 over other PDE subtypes. The present invention also provides pharmaceutical compositions comprising compounds of the invention and methods of treating disorders using the compounds of the invention.
priorityDate 2011-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID63885
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID10846
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457484072
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23984

Total number of triples: 31.